Our team
Overview
Our Cambridge team brings together consultants, researchers and analysts with deep expertise across market access, health economics, forecasting, life sciences research, statistics and economic modelling, working alongside a wider network of specialist associates and partners.
Together, this expertise gives every project the right mix of skills and experience for the task at hand.
The team is led by Directors David Alderson and James Morris, and works with pharmaceutical, biotech and life science companies globally to deliver evidence that informs real decisions.
As part of the Helios Global Group (link), our reach continues to grow and we are looking for people who want to help to shape that growth, bringing fresh thinking to complex evidence and access challenges. In return, we give our team the time, trust and support to do their best work.
Business Development team
David Alderson
Project Director
Strategic Market Access
David is Director leading the market access team at Cogentia. His interest is in problem solving and developing integrated, evidence-based solutions to new and perennial access challenges.
He brings a wealth of experience from over 30 years in the industry, within many different multi-disciplinary teams and companies, spanning both industry and consulting, and global and national roles.
James Morris
Project Director
Health Economics and HTA
James is Founder and Director at Cogentia, having established the company in 2010. Prior to setting up Cogentia, James worked in industry for over 10 years, including European and UK leadership roles in Health Technology Assessment and Health Economics and Outcomes Research in big pharma. James has led on well over 150 HTAs across multiple European markets and therapeutic areas, encompassing all aspects from early model development through to pricing…
Abbey Child
Head of Market Access
Strategic Market Access
Abbey is Head of Market Access at Cogentia. She has a wide range of experience managing and delivering across our strategic market access offerings, with a particular interest in opportunity assessment and strategy development. Specifically, she aims to integrate expertise from a variety of sources, resulting in the development of comprehensive market access strategy…
Vanessa Buchanan
Head of Health Economics and HTA
Health Economics and HTA
Vanessa is Head of Health Economics and HTA at Cogentia.
Vanessa has hands-on experience of all aspects of economic evaluation including decision modelling and evidence synthesis. She also has broad experience of supporting product development, pricing and reimbursement and launch, including biologics, chemotherapies and orphan products…
Get in touch
We welcome conversations with prospective clients, collaborators and individuals interested in joining our team. To find out more about how Cogentia can support your work, please get in touch.